https://scholars.lib.ntu.edu.tw/handle/123456789/623263| Title: | Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis | Authors: | TUNG-HUNG SU Peng, Cheng-Yuan Chang, Shan-Han Tseng, Tai-Chung Liu, Chun-Jen Chen, Chi-Ling Liu, Chen-Hua Yang, Hung-Chih Chen, Pei-Jer Kao, Jia-Horng |
Keywords: | AFP; DCP; Des-carboxyprothrombin; Liver cancer; Prothrombin induced by vitamin K Absence or antagonist-II | Issue Date: | Mar-2022 | Publisher: | ELSEVIER TAIWAN | Journal Volume: | 121 | Journal Issue: | 3 | Start page/Pages: | 703 | Source: | Journal of the Formosan Medical Association = Taiwan yi zhi | Abstract: | The risk of hepatocellular carcinoma (HCC) is reduced but not eliminated after nucleos(t)ide analogue (NA) therapy in chronic hepatitis B (CHB). We aimed to investigate the role of serum Prothrombin Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) and alpha-fetoprotein in predicting HCC and mortality in cirrhotic CHB patients at virological remission (VR) following NA therapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/623263 | ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2021.08.003 |
| Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.